186 related articles for article (PubMed ID: 17592750)
1. Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb.
Vroon A; Drukarch B; Bol JG; Cras P; Brevé JJ; Allan SM; Relton JK; Hoogland PV; Van Dam AM
Exp Gerontol; 2007 Aug; 42(8):762-71. PubMed ID: 17592750
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
Kim S; Moon M; Park S
J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
[TBL] [Abstract][Full Text] [Related]
4. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease.
Depboylu C; Schorlemmer K; Klietz M; Oertel WH; Weihe E; Höglinger GU; Schäfer MK
J Neuroimmunol; 2011 Jul; 236(1-2):39-46. PubMed ID: 21640391
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
[TBL] [Abstract][Full Text] [Related]
7. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
8. Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
Hébert G; Mingam R; Arsaut J; Dantzer R; Demotes-Mainard J
Brain Res Mol Brain Res; 2005 Aug; 138(2):156-63. PubMed ID: 15922486
[TBL] [Abstract][Full Text] [Related]
9. MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain.
Lofrumento DD; Saponaro C; Cianciulli A; De Nuccio F; Mitolo V; Nicolardi G; Panaro MA
Neuroimmunomodulation; 2011; 18(2):79-88. PubMed ID: 20938211
[TBL] [Abstract][Full Text] [Related]
10. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
12. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.
Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK
Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514
[TBL] [Abstract][Full Text] [Related]
13. In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization.
Shen YQ; Hebert G; Su Y; Moze E; Neveu PJ; Li KS
Brain Res; 2005 May; 1045(1-2):31-7. PubMed ID: 15910760
[TBL] [Abstract][Full Text] [Related]
14. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
[TBL] [Abstract][Full Text] [Related]
15. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
Kurkowska-Jastrzebska I; Bałkowiec-Iskra E; Ciesielska A; Joniec I; Cudna A; Zaremba MM; Członkowski A; Członkowska A
Int Immunopharmacol; 2009 Jun; 9(6):781-91. PubMed ID: 19286483
[TBL] [Abstract][Full Text] [Related]
16. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
[TBL] [Abstract][Full Text] [Related]
17. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
[TBL] [Abstract][Full Text] [Related]
19. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
[TBL] [Abstract][Full Text] [Related]
20. Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice.
Cardenas H; Bolin LM
Brain Res; 2003 Sep; 985(1):89-97. PubMed ID: 12957371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
